An investigation for blood 25 (OH) D concentration and intervention study in hypertension population with low serum 25 (OH) D concentration in Urumqi

The serum 25 (OH) D level investigation and intervention study in Urumqi hypertension

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12001910

Enrollment

Unknown

Registered

2012-01-27

Start date

2011-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

1:Calcium antagonists and Calcitriol capsule treatme

2:Calcium antagonists and Calcitriol placebo capsule treatme

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Hypertention patients with low level of 25 (OH) D. In patients with high blood pressure control guidelines in 2005 China diagnostic criteria level 1 or 2 class of essential hypertension patients; Blood 25 (OH) D level < 20 ng/ml (50 nmol/L), patients in xinjiang region live within three years, in the period of normal diet and intervention to keep time, outdoor activities and medication use calcium antagonists.

Exclusion criteria

Exclusion criteria: Patients took calcium and vitamin agent in past two months; Patients suffered infection, trauma, surgeries in past one month; Patients suffered acute cardiovascular events; New hair of cerebrovascular disease, peripheral vascular thrombosis sex disease; Thyroid function with hyperthyroidism, thyroid function is low, parathyroid gland disease, metabolic bone diseases, serious liver and kidney function not whole; Malignant tumor and autoimmune diseases.

Design outcomes

Primary

Measure	Time frame
25(OH)D;	—

Countries

China

Contacts

Public ContactXu Xinjuan

zcxu2002@medmail.com.cn+86 13899956736

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026